Ch. 37

Question 1

Three classes of bronchodilators

Answer 1

beta-adrenergic agonists
anticholinergics
xanthine derivatives

Question 2

albuterol

Answer 2

 Short-acting beta agonist (SABA) inhalers

Question 3

levalbuterol

Answer 3

 Short-acting beta agonist (SABA) inhalers

Question 4

pirbuterol

Answer 4

 Short-acting beta agonist (SABA) inhalers

Question 5

terbutaline

Answer 5

 Short-acting beta agonist (SABA) inhalers

Question 6

metaproterenol

Answer 6

Short-acting beta agonist (SABA) inhalers

Question 7

 arformoterol

Answer 7

Long-acting beta agonist (LABA) inhalers

Question 8

formoterol

Answer 8

Long-acting beta agonist (LABA) inhalers

Question 9

salmoterol

Answer 9

Long-acting beta agonist (LABA) inhalers

Question 10

ipratropium

Answer 10

Anticholinergic

Question 11

tiotropium

Answer 11

Anticholinergic

Question 12

 The only usual contraindication to the use of ___________ is drug allergy, including allergy to atropine or to soy lecithin, or allergy to related food products such as peanut oils, peanuts, soybeans, and other legumes.

Answer 12

Anticholinergic

Question 13

Cause bronchodilation by increasing the levels of the energy-producing substance cyclic adenosine monophosphate (cAMP). They do this by competitively inhibiting phosphodiesterase, the enzyme responsible for breaking down cAMP.

Answer 13

xanthines

Question 14

aminophylline

Answer 14

synthetic xanthines

Question 15

dyphylline

Answer 15

synthetic xanthines

Question 16

montelukast

Answer 16

leukotriene receptor antagonists

Question 17

zafirlukast

Answer 17

leukotriene receptor antagonists

Question 18

zileuton

Answer 18

leukotriene receptor antagonists

Question 19

beclomethasone

Answer 19

corticosteroid

Question 20

budesonide

Answer 20

corticosteroid

Question 21

dexamethasone

Answer 21

corticosteroid

Question 22

flunisolide

Answer 22

corticosteroid

Question 23

fluticasone

Answer 23

corticosteroid

Question 24

ciclesonide

Answer 24

corticoseroid

Question 25

triamcinolone

Answer 25

corticosteroid

Question 26

roflumilast

Answer 26

Phosphodiesterase-4 Inhibitor

Question 27

A selective inhibitor of the enzyme called phosphodiesterase type 4 (PDE4), indicated to prevent coughing and excess mucus from worsening and to decrease the frequency of life-threatening COPD exacerbations. It is not intended to treat acute bronchospasm.

Answer 27

roflumilast

Question 28

A monoclonal antibody that selectively binds to the immunoglobulin IgE, which in turn limits the release of mediators of the allergic response.

Answer 28

 omalizumab

Question 29

cromolyn

Answer 29

Mast Cell Stabilizers

Question 30

nedocromyl

Answer 30

Mast Cell Stablizer

Question 31

MOA: Stabilize the cell membranes of mast cells, preventing the release of substances, such as histamine, that cause bronchoconstriction

Answer 31

cromolyn

nedocromyl